You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 13, 14 JULY 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEW ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Association of Microalbuminuria and Mortality in Non—Insulin-Dependent Diabetes Mellitus

A Systematic Overview of the Literature

Sean F. Dinneen, MD, MSc, FRCPI; Hertzel C. Gerstein, MD, MSc, FRCPC

Arch Intern Med. 1997;157(13):1413-1418.


Abstract

Objectives
To critically analyze the literature linking microalbuminuria with total and cardiovascular mortality and cardiovascular morbidity in non—insulin— dependent diabetes mellitus (NIDDM) and to quantify the risk.

Methods
A combination of retrieval techniques (MEDLINE, SCISEARCH, and handsearching published bibliographies) was used to find all relevant articles based on title and abstract and "Methods" sections. Unpublished data on albumin excretion rate were sought from large NIDDM cohort studies.

Results
A total of 264 citations were retrieved, of which 11 cohort studies were selected for inclusion in the overview, representing a total of 2138 patients followed up for a mean of 6.4 years. Patient age was similar across cohorts. Duration of NIDDM ranged from newly diagnosed to 13 years. The prevalence of microalbuminuria ranged from 20% to 36% in the 8 cohorts that excluded patients with clinical proteinuria. All studies reported either a trend or a significant association between microalbuminuria and total mortality or cardiovascular morbidity or mortality; the overall odds ratio for death was 2.4 (95% confidence interval, 1.8-3.1) and for cardiovascular morbidity or mortality, 2.0 (95% confidence interval, 1.4-2.7). We found no evidence of reporting bias.

Conclusion
Microalbuminuria is a strong predictor of total and cardiovascular mortality and cardiovascular morbidity in patients with NIDDM.

Arch Intern Med. 1997;157:1413-1418



Author Affiliations

From the Division of Endocrinology, Mayo Clinic, Rochester, Minn (Dr Dinneen), and the Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario (Dr Gerstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Fukui et al.
CJASN 2009;4:1761-1765.
ABSTRACT | FULL TEXT  

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes
Gagliardini et al.
Am. J. Physiol. Renal Physiol. 2009;297:F1448-F1456.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria
Delea et al.
J. Am. Soc. Nephrol. 2009;20:2205-2213.
ABSTRACT | FULL TEXT  

Angiotensin-Receptor Blockers in the Prevention or Treatment of Microalbuminuria
Parfrey
ANN INTERN MED 2009;151:63-65.
FULL TEXT  

Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials
Bilous et al.
ANN INTERN MED 2009;151:11-20.
ABSTRACT | FULL TEXT  

Association of CKD and Cancer Risk in Older People
Wong et al.
J. Am. Soc. Nephrol. 2009;20:1341-1350.
ABSTRACT | FULL TEXT  

Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
Kramer et al.
Nephrol Dial Transplant 2009;24:1193-1196.
ABSTRACT | FULL TEXT  

Changes in Albumin Excretion in the Diabetes Prevention Program
Diabetes Prevention Program Research Group
Diabetes Care 2009;32:720-725.
ABSTRACT | FULL TEXT  

Myogenic tone and small artery remodelling: insight into diabetic nephropathy
Khavandi et al.
Nephrol Dial Transplant 2009;24:361-369.
FULL TEXT  

CHAPTER 13 Hypertension
Kjeldsen et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease
Radbill et al.
Mayo Clin Proc. 2008;83:1373-1381.
ABSTRACT | FULL TEXT  

Comparison between Immunoturbidimetry, Size-Exclusion Chromatography, and LC-MS to Quantify Urinary Albumin
Shaikh et al.
Clin. Chem. 2008;54:1504-1510.
ABSTRACT | FULL TEXT  

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
Ruggenenti et al.
Diabetes Care 2008;31:1629-1634.
ABSTRACT | FULL TEXT  

Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease
Suliman et al.
CJASN 2008;3:976-985.
ABSTRACT | FULL TEXT  

Importance of Low-Grade Albuminuria
Danziger
Mayo Clin Proc. 2008;83:806-812.
ABSTRACT | FULL TEXT  

Urinary Smad1 Is a Novel Marker to Predict Later Onset of Mesangial Matrix Expansion in Diabetic Nephropathy
Mima et al.
Diabetes 2008;57:1712-1722.
ABSTRACT | FULL TEXT  

Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study
Rossi et al.
Nephrol Dial Transplant 2008;23:1278-1284.
ABSTRACT | FULL TEXT  

Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria
de Jong and Gansevoort
Nephrol Dial Transplant 2008;23:1092-1095.
FULL TEXT  

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
Palmer et al.
Nephrol Dial Transplant 2008;23:1216-1223.
ABSTRACT | FULL TEXT  

White Blood Cells Telomere Length Is Shorter in Males With Type 2 Diabetes and Microalbuminuria
Tentolouris et al.
Diabetes Care 2007;30:2909-2915.
ABSTRACT | FULL TEXT  

Association Between Urinary Albumin Excretion and Plasma 5-Hydroxyindole-3-Acetic Acid Concentration in Men With Type 2 Diabetes
Fukui et al.
Diabetes Care 2007;30:2649-2651.
FULL TEXT  

Diabetes Management Issues for Patients With Chronic Kidney Disease
Cavanaugh
Clin. Diabetes 2007;25:90-97.
ABSTRACT | FULL TEXT  

Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentrations in Women With Type 2 Diabetes
Fukui et al.
Diabetes Care 2007;30:1886-1888.
FULL TEXT  

Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Araki et al.
Diabetes 2007;56:1727-1730.
ABSTRACT | FULL TEXT  

The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes
Tong et al.
Diabetes Care 2007;30:1206-1211.
ABSTRACT | FULL TEXT  

Deletion of Protein Kinase C-{beta} Isoform In Vivo Reduces Renal Hypertrophy but Not Albuminuria in the Streptozotocin-Induced Diabetic Mouse Model
Meier et al.
Diabetes 2007;56:346-354.
ABSTRACT | FULL TEXT  

High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria
Tentolouris et al.
J. Lipid Res. 2007;48:218-225.
ABSTRACT | FULL TEXT  

Irbesartan Treatment Reduces Biomarkers of Inflammatory Activity in Patients With Type 2 Diabetes and Microalbuminuria: An IRMA 2 Substudy
Persson et al.
Diabetes 2006;55:3550-3555.
ABSTRACT | FULL TEXT  

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial
Ruggenenti et al.
J. Am. Soc. Nephrol. 2006;17:3472-3481.
ABSTRACT | FULL TEXT  

Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review
Carter et al.
Nephrol Dial Transplant 2006;21:3031-3037.
FULL TEXT  

Chip Electrophoresis as a Method for Quantifying Total Microalbuminuria
Chan and Herold
Clin. Chem. 2006;52:2141-2146.
ABSTRACT | FULL TEXT  

Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
Sarafidis and Bakris
Nephrol Dial Transplant 2006;21:2366-2374.
FULL TEXT  

Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
Molitch
CJASN 2006;1:1090-1099.
ABSTRACT | FULL TEXT  

Best practice in primary care pathology: review 3.
Smellie et al.
J. Clin. Pathol. 2006;59:781-789.
ABSTRACT | FULL TEXT  

Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
Stehouwer and Smulders
J. Am. Soc. Nephrol. 2006;17:2106-2111.
ABSTRACT | FULL TEXT  

Microalbuminuria as an Early Marker for Cardiovascular Disease
de Zeeuw et al.
J. Am. Soc. Nephrol. 2006;17:2100-2105.
ABSTRACT | FULL TEXT  

Obesity, diabetes and cardiovascular disease: is the fat lady singing?
Grant
Diabetes and Vascular Disease Research 2006;3:5-6.
 

Prevalence of microalbuminuria and hypertension in South Asians and white Europeans with type 2 diabetes: a report from the United Kingdom Asian Diabetes Study (UKADS)
Dixon et al.
Diabetes and Vascular Disease Research 2006;3:22-25.
ABSTRACT  

Microalbuminuria Is Determined by Systolic and Pulse Pressure Over a 12-Year Period and Related to Peripheral Artery Disease in Normotensive and Hypertensive Subjects: The Three Areas Study in Greece (TAS-GR)
Tsakiris et al.
ANGIOLOGY 2006;57:313-320.
ABSTRACT  

A Pen-and-Paper Coronary Risk Estimator for Office Use With Patients With Type 2 Diabetes
Christianson et al.
Mayo Clin Proc. 2006;81:632-636.
ABSTRACT | FULL TEXT  

Serum Uric Acid Is Associated With Microalbuminuria in Prehypertension
Lee et al.
Hypertension 2006;47:962-967.
ABSTRACT | FULL TEXT  

Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients
Segura et al.
J. Am. Soc. Nephrol. 2006;17:S136-S140.
ABSTRACT | FULL TEXT  

Higher Levels of HDL Cholesterol Are Associated With a Decreased Likelihood of Albuminuria in Patients With Long-Standing Type 1 Diabetes
Molitch et al.
Diabetes Care 2006;29:78-82.
ABSTRACT | FULL TEXT  

Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study
Xu et al.
British Journal of Diabetes & Vascular Disease 2005;5:334-340.
ABSTRACT  

Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes
Araki et al.
Diabetes 2005;54:2983-2987.
ABSTRACT | FULL TEXT  

Antihypertensive Agents for Primary Prevention of Diabetic Nephropathy
Strippoli et al.
J. Am. Soc. Nephrol. 2005;16:3081-3091.
ABSTRACT | FULL TEXT  

Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study
Arnlov et al.
Circulation 2005;112:969-975.
ABSTRACT | FULL TEXT  

Modest Salt Reduction Reduces Blood Pressure and Urine Protein Excretion in Black Hypertensives: A Randomized Control Trial
Swift et al.
Hypertension 2005;46:308-312.
ABSTRACT | FULL TEXT  

Relationship between Albuminuria and Cardiovascular Disease in Type 2 Diabetes
Freedman et al.
J. Am. Soc. Nephrol. 2005;16:2156-2161.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence: The EURODIAB Prospective Complications Study
van Hecke et al.
Diabetes Care 2005;28:1383-1389.
ABSTRACT | FULL TEXT  

Renal manifestations of the metabolic syndrome
Tuttle
Nephrol Dial Transplant 2005;20:861-864.
FULL TEXT  

Graded Effects of Proteinuria on HDL Structure in Nephrotic Rats
Shearer et al.
J. Am. Soc. Nephrol. 2005;16:1309-1319.
ABSTRACT | FULL TEXT  

Aortic Pulse Wave Velocity and Albuminuria in Patients with Type 2 Diabetes
Smith et al.
J. Am. Soc. Nephrol. 2005;16:1069-1075.
ABSTRACT | FULL TEXT  

Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study
Suarez et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:240-245.
ABSTRACT | FULL TEXT  

Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population
Furtner et al.
Eur Heart J 2005;26:279-287.
ABSTRACT | FULL TEXT  

Association between Chronic Kidney Disease and Coronary Artery Calcification: The Dallas Heart Study
Kramer et al.
J. Am. Soc. Nephrol. 2005;16:507-513.
ABSTRACT | FULL TEXT  

Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
Gross et al.
Diabetes Care 2005;28:164-176.
ABSTRACT | FULL TEXT  

Reduced glomerular filtration rate in asymptomatic diabetic patients: Predictor of increased risk for cardiac events independent of albuminuria
Knobler et al.
J Am Coll Cardiol 2004;44:2142-2148.
ABSTRACT | FULL TEXT  

Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentration in Male Patients With Type 2 Diabetes: A possible link between urinary albumin excretion and cardiovascular disease
Fukui et al.
Diabetes Care 2004;27:2893-2897.
ABSTRACT | FULL TEXT  

Evaluation of Measures of Urinary Albumin Excretion in Epidemiologic Studies
Dyer et al.
Am J Epidemiol 2004;160:1122-1131.
ABSTRACT | FULL TEXT  

Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti et al.
NEJM 2004;351:1941-1951.
ABSTRACT | FULL TEXT  

Recent advances in diabetic nephropathy
Marshall
Postgrad. Med. J. 2004;80:624-633.
ABSTRACT | FULL TEXT  

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
Strippoli et al.
BMJ 2004;329:828.
ABSTRACT | FULL TEXT  

Treatment of Hypertension in Patients With Diabetes
Sowers
Arch Intern Med 2004;164:1850-1857.
ABSTRACT | FULL TEXT  

Cardiovascular Disease, Mortality, and Retinal Microvascular Characteristics in Type 1 Diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Intern Med 2004;164:1917-1924.
ABSTRACT | FULL TEXT  

The `polypill' to reduce cardiovascular risk: proof of concept: Data from the Steno-2 multifactorial intervention study in type 2 diabetes supports the `polypill' strategy to reduce cardiovascular risk
Patel et al.
British Journal of Diabetes & Vascular Disease 2004;4:339-341.
ABSTRACT  

Estimating Laboratory Precision of Urinary Albumin Excretion and Other Urinary Measures in the International Study on Macronutrients and Blood Pressure
Dyer et al.
Am J Epidemiol 2004;160:287-294.
ABSTRACT | FULL TEXT  

Diminished Loss of Proteoglycans and Lack of Albuminuria in Protein Kinase C-{alpha}--Deficient Diabetic Mice
Menne et al.
Diabetes 2004;53:2101-2109.
ABSTRACT | FULL TEXT  

Review: Diabetes and the QT interval: time for debate
Kumar et al.
British Journal of Diabetes & Vascular Disease 2004;4:146-150.
ABSTRACT  

Review: Renal dysfunction as a marker of increased vascular risk
Andrews
British Journal of Diabetes & Vascular Disease 2004;4:152-155.
ABSTRACT  

A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study
Yuyun et al.
Am J Epidemiol 2004;159:284-293.
ABSTRACT | FULL TEXT  

Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
Yuyun et al.
Int J Epidemiol 2004;33:189-198.
ABSTRACT | FULL TEXT  

Optimization of Hypolipidemic and Antiplatelet Treatment in the Diabetic Patient with Renal Disease
Trovati and Cavalot
J. Am. Soc. Nephrol. 2004;15:S12-20.
ABSTRACT | FULL TEXT  

Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
Wachtell et al.
ANN INTERN MED 2003;139:901-906.
ABSTRACT | FULL TEXT  

Microalbuminuria and All-Cause Mortality in Treated Hypertensive Individuals: Does Sex Matter?: The Nord-Trondelag Health Study (HUNT), Norway
Romundstad et al.
Circulation 2003;108:2783-2789.
ABSTRACT | FULL TEXT  

The Degree of Albuminuria Is Related to Left Ventricular Hypertrophy in Hypertensive Diabetics and Is Associated with Abnormal Left Ventricular Filling: A Pilot Study
Salmasi et al.
ANGIOLOGY 2003;54:671-678.
ABSTRACT  

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Sarnak et al.
Hypertension 2003;42:1050-1065.
FULL TEXT  

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Sarnak et al.
Circulation 2003;108:2154-2169.
FULL TEXT  

Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Zandbergen et al.
ANN INTERN MED 2003;139:90-96.
ABSTRACT | FULL TEXT  

Significance of Microalbuminuria in Long-Duration Type 1 Diabetes
Arun et al.
Diabetes Care 2003;26:2144-2149.
ABSTRACT | FULL TEXT  

Middle Age Cardiovascular Risk Factors and Abdominal Aortic Aneurysm in Older Age
Rodin et al.
Hypertension 2003;42:61-68.
ABSTRACT | FULL TEXT  

Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria: Observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study
Vaur et al.
Diabetes Care 2003;26:855-860.
ABSTRACT | FULL TEXT  

Development of Renal Disease in People at High Cardiovascular Risk: Results of the HOPE Randomized Study
Mann et al.
J. Am. Soc. Nephrol. 2003;14:641-647.
ABSTRACT | FULL TEXT  

Prevalence, Awareness, Treatment, and Control of Hypertension in China
Gu et al.
Hypertension 2002;40:920-927.
ABSTRACT | FULL TEXT  

Proteinuria as a Predictor of Total Plasma Homocysteine Levels in Type 2 Diabetic Nephropathy
Friedman et al.
Diabetes Care 2002;25:2037-2041.
ABSTRACT | FULL TEXT  

Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes
Diercks et al.
J Am Coll Cardiol 2002;40:1401-1407.
ABSTRACT | FULL TEXT  

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population
Hillege et al.
Circulation 2002;106:1777-1782.
ABSTRACT | FULL TEXT  

Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus: A Blood Pressure-Independent Effect
Viberti et al.
Circulation 2002;106:672-678.
ABSTRACT | FULL TEXT  

Animal Versus Plant Protein Meals in Individuals With Type 2 Diabetes and Microalbuminuria: Effects on renal, glycemic, and lipid parameters
Wheeler et al.
Diabetes Care 2002;25:1277-1282.
ABSTRACT | FULL TEXT  

Significance of silent ischemia andmicroalbuminuria in predicting coronaryevents in asymptomatic patients with type 2 diabetes
Rutter et al.
J Am Coll Cardiol 2002;40:56-61.
ABSTRACT | FULL TEXT  

Difference in the Relation Between Urinary Albumin Excretion and Carotid Intima-Media Thickness in Nondiabetic and Type 2 Diabetic Subjects
Diercks et al.
Diabetes Care 2002;25:936-937.
FULL TEXT  

Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death
Stehouwer et al.
Diabetes 2002;51:1157-1165.
ABSTRACT | FULL TEXT  

C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk
Jager et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:593-598.
ABSTRACT | FULL TEXT  

Screening for microalbuminuria
Kirby
British Journal of Diabetes & Vascular Disease 2002;2:106-109.
 

Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S.
Caro et al.
Diabetes Care 2002;25:476-481.
ABSTRACT | FULL TEXT  

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Garg and Bakris
Vasc Med 2002;7:35-43.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.